SCHEIN JOSHUA D 4
4 · Lev Pharmaceuticals Inc · Filed Jun 14, 2006
Insider Transaction Report
Form 4
SCHEIN JOSHUA D
DirectorCEO10% Owner
Transactions
- Purchase
Common Stock
2006-06-13$0.59/sh+1,500$885→ 996,005 total - Purchase
Common Stock
2006-06-13$0.56/sh+1,000$560→ 994,505 total
Holdings
- 27,473,417(indirect: see footnote)
Common Stock
Footnotes (1)
- [F1]Consists of shares of common stock owned by Prism Ventures, a limited liability company in which Mr. Schein owns a 50% interest, and the following entities, all of which are owned by Prism Ventures, LLC: Newton Partners, LLC, Windsor Ventures, LLC, Sapphire Ventures, LLC, Tudor Technology Ventures, LLC and Entry Point Capital LLC.